Ketone bodies affect the enzymatic activity of macrophage migration inhibitory factor

Life Sciences

Volumn 77, Issue 12, 2005, Pages 1375-1380

  Garai, János ^a   Lóránd, Tamás ^a   Molnár, Valéria ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Diketones; Ketone bodies; MIF; Tautomerase

Indexed keywords

CYTOKINE; KETONE BODY; MACROPHAGE MIGRATION INHIBITION FACTOR; PHENYLPYRUVIC ACID;

ARTICLE; ENZYME ACTIVITY; ENZYME ANALYSIS; SPECTROPHOTOMETRY;

ENZYME INHIBITORS; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; KETONE BODIES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MACROPHAGES; PHOSPHOPYRUVATE HYDRATASE;

EID: 21744447832     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2005.03.010     Document Type: Article

References (29)

1. T. Atsumi, J. Nishihira, Z. Makita, and T. Koike Enhancement of oxidised low-density lipoprotein uptake by macrophages in response to macrophage migration inhibitory factor Cytokine 12 10 2000 1553 1556
2. J. Bernhagen, T. Calandra, R.A. Mitchell, S.B. Martin, K.J. Tracey, W. Voelter, K.R. Manogue, A. Cerami, and R. Bucala MIF is a pituitary-derived cytokine that potentiates endotoxinaemia Nature 365 6448 1993 756 759
3. A. Burger-Kentischer, H. Goebel, R. Seiler, G. Fraedrich, H.E. Schaefer, S. Dimmeler, R. Kleemann, J. Bernhagen, and C. Ihling Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis Circulation 105 13 2002 1561 1566
4. Y. Cheng, and W.H. Prusoff Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (IC50) of an enzymatic reaction Biochemical Pharmacology 22 23 1973 3099 3108
5. P. Dandona, A. Aljada, H. Ghanim, P. Mohanty, C. Tripathy, D. Hofmeyer, and A. Chaudhury Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin Journal of Clinical Endorynology and Metabolism 89 10 2004 5043 5047
6. A. Dios, R.A. Mitchell, B. Aljabari, J. Lubetsky, K.A. O'Connor, H. Liao, P.D. Senter, K.R. Manogue, E. Lolis, C. Metz, R. Bucala, D.J.E. Callaway, and Y. Al-Abed Inhibition of MIF bioactivity by rational design of pharmacological inhibitors of MIF tautomerase activity Journal of Medicinal Chemistry 45 12 2002 2410 2416
7. A. Hermanowski-Vosatka, S.S. Mundt, J.M. Ayala, S. Goyal, W.A. Hanlon, R.M. Czerwinski, S.D. Wright, and C.P. Whitman Enzymatically inactive macrophage migration inhibitory factor inhibits monocyte chemotaxis and random migration Biochemistry 38 39 1999 12841 12849
8. S. Hunig, E. Benzing, and E. Lucke Synthesis with enamines: I. Acylation with carboxylic acid chlorides Chemische Berichte 90 1957 2833 2840
9. S.K. Jain, R. McVie, J.J. Jaramillo, and Y. Chen Hyperketonemia (acetoacetate) increases the oxidizability of LDL+VLDL in type-1 diabetic patients Free Radical Biology & Medicine 24 1 1998 175 181
10. M.P. Kalapos On the mammalian acetone metabolism: from chemistry to clinical implications Biochimica et Biophysica Acta 1621 2 2003 122 139
11. R. Kleemann, A. Kaporniotu, R.W. Frank, A. Gessner, R. Mischke, O. Flieger, S. Jüttner, H. Brunner, and J. Bernhagen Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-protein oxidoreductase Journal of Molecular Biology 280 1 1998 85 102
12. S. Lanza-Jacoby, E. Rosato, G. Braccia, and A. Tabares Altered ketone body metabolism during gram-negative sepsis in the rat Metabolism 39 11 1990 1151 1157
13. M. Leech, C. Metz, P. Hall, P. Hutchinson, K. Gianis, M. Smith, H. Weedon, S.R. Holdsworth, R. Bucala, and E.F. Morand Macrophage migration inhibitory factor in rheumatoid arthritis-evidence of pro-inflammatory function and regulation by glucocorticoids Arthritis and Rheumatism 42 8 1999 1601 1608
14. E. Lolis, and R. Bucala Macrophage migration inhibitory factor Expert Opinion on Therapeutic Targets 7 2 2003 153 164
15. E.F. Morand, M. Leech, H. Weedon, C. Metz, R. Bucala, and M.D. Smith Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations Rheumatology 41 5 2002 558 562 (Oxford)
16. D. Naughton, M. Whelan, E.C. Smith, R. Williams, D.R. Blake, and M. Grootveld An investigation of the abnormal metabolic status of synovial fluid from patients with rheumatoid arthritis by high field proton nuclear magnetic resonance spectroscopy FEBS Letters 317 1-2 1993 135 138
17. H.A. Neufeld, J.A. Pace, and E. White The effect of bacterial infections on ketone concentrations in rat liver and blood and on free fatty acid concentrations in rat blood Metabolism, Clinical and Experimental 25 8 1976 877 884
18. J. Nishihira Macrophage migration inhibitory factor (MIF): its essential role in the immune system and cell growth Journal of Interferon and Cytokine Research 20 9 2000 751 762
19. E. Rosengren, R. Bucala, P. Åman, L. Jacobsson, G. Odh, C.N. Metz, and H. Rorsman The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction Molecular Medicine 2 1 1996 143 149
20. E. Rosengren, P. Åman, S. Thelin, C. Hansson, S. Ahlfors, P. Bjoërk, L. Jacobsson, and H. Rorsman The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomerase FEBS Letters 417 1 1997 85 88
21. N. Sato, H. Shimizu, Y. Shirmomura, K. Suwa, M. Mori, and I. Kobayashi Mechanism of inhibitory action of ketone bodies on the production of reactive oxygen intermediates (ROIS) by polymorphonuclear leukocytes Life Sciences 51 2 1992 113 118
22. F. Sjogren, O. Groth, and C. Anderson Acetone has anti-inflammatory effects on experimental contact reactions Contact Dermatitis 41 1 1999 22 29
23. S.L. Stamps, M.C. Fitzgerald, and C.P. Whitman Characterization of the role of the amino-terminal proline in the enzymatic activity catalyzed by macrophage migration inhibitory factor Biochemistry 37 28 1998 10195 10202
24. W. Suriyasathaporn, A.J.J.M. Daemen, E.N. Nordhuizen-Stassen, S.J. Dieleman, M. Nielen, and Y.H. Schukken β-Hydroxybutyrate levels in peripheral blood and ketone bodies supplemented in culture media affect the in vitro chemotaxis of bovine leukocytes Veterinary Immunology and Immunopathology 68 2-4 1999 177 186
25. M. Swope, H-W. Sun, P.R. Blake, and E. Lolis Direct link between cytokine activity and a catalytic site for macrophage migration inhibitory factor EMBO Journal 17 13 1998 3524 3541
26. A.B. Taylor, W.H. Johnson Jr., R.M. Czerwinski, H.S. Li, L.M. Hackert, and C.P. Whitman Crystal structure of macrophage migration inhibitory factor complexed with (E)-2-fluoro-p-hydroxycinnamate at 1.8 Å resolution: implications for enzymatic catalysis and inhibition Biochemistry 38 23 1999 7444 7452
27. H. Watarai, and N. Suzuki Keto-enol tautomerization rates of acetylacetone in mixed aqueous media Journal of Inorganic and Nuclear Chemistry 36 8 1974 1815 1820
28. P.G. Winyard, F. Tatzber, H. Esterbauer, M.L. Kus, D.R. Blake, and C.J. Morris Presence of foam cells containing oxidised low density lipoprotein in the synovial membrane from patients with rheumatoid arthritis Annals of Rheumatic Diseases 52 9 1993 677 680
29. N. Yabunaka, J. Nishihira, Y. Mizue, M. Tsuji, M. Kumagai, Y. Ohtsuka, M. Imamura, and M. Asaka Elevated serum content of macrophage migration inhibitory factor in patients with type 2 diabetes Diabetes Care 23 2 2000 256 258